{
    "id": 23698,
    "fullName": "CUX1 - FGFR1",
    "impact": "fusion",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "CUX1-FGFR1 results from the fusion of CUX1 and FGFR1, demonstrating kinase-driven cytokine-independent growth in culture and constitutive phosphorylation activity (PMID: 21330321). CUX1-FGFR1 fusions have been identified in T-lymphoblastic leukemia/lymphomas (PMID: 21330321).",
            "references": [
                {
                    "id": 6082,
                    "pubMedId": 21330321,
                    "title": "The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21330321"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 1523,
        "geneSymbol": "CUX1",
        "terms": [
            "CUX1",
            "CASP",
            "CDP",
            "CDP/Cut",
            "CDP1",
            "Clox",
            "COY1",
            "CUTL1",
            "CUX",
            "Cux/CDP",
            "GDDI",
            "GOLIM6",
            "Nbla10317",
            "p100",
            "p110",
            "p200",
            "p75"
        ]
    },
    "variant": "CUX1 - FGFR1",
    "createDate": "06/26/2016",
    "updateDate": "12/09/2018",
    "referenceTranscriptCoordinates": null,
    "partnerGenes": [
        {
            "gene": {
                "id": 2260,
                "geneSymbol": "FGFR1",
                "terms": [
                    "FGFR1",
                    "bFGF-R-1",
                    "BFGFR",
                    "CD331",
                    "CEK",
                    "ECCL",
                    "FGFBR",
                    "FGFR-1",
                    "FLG",
                    "FLT-2",
                    "FLT2",
                    "HBGFR",
                    "HH2",
                    "HRTFDS",
                    "KAL2",
                    "N-SAM",
                    "OGD"
                ]
            }
        }
    ],
    "evidence": [
        {
            "id": 15414,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Iclusig (ponatinib) treatment of transformed murine B cells expressing CUX1-FGFR1, resulted in decreased cell growth and reduced phosphorylation of CUX1-FGFR1 and downstream targets (PMID: 21330321).",
            "molecularProfile": {
                "id": 24416,
                "profileName": "CUX1 - FGFR1"
            },
            "therapy": {
                "id": 877,
                "therapyName": "Ponatinib",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6082,
                    "pubMedId": 21330321,
                    "title": "The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21330321"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15412,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Dovitinib (TKI258) treatment of transformed murine B cells expressing CUX1-FGFR1, resulted in decreased cell growth and phosphorylation of CUX1-FGFR1 (PMID: 21330321).",
            "molecularProfile": {
                "id": 24416,
                "profileName": "CUX1 - FGFR1"
            },
            "therapy": {
                "id": 721,
                "therapyName": "Dovitinib",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 6082,
                    "pubMedId": 21330321,
                    "title": "The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21330321"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 15413,
            "approvalStatus": "Preclinical - Cell culture",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Rydapt (midostaurin, PKC412) treatment of transformed murine B cells expressing CUX1-FGFR1, resulted in decreased cell growth and increased apoptosis, but response may not be specific to inhibition of CUX1-FGFR1 (PMID: 21330321).",
            "molecularProfile": {
                "id": 24416,
                "profileName": "CUX1 - FGFR1"
            },
            "therapy": {
                "id": 810,
                "therapyName": "Midostaurin",
                "synonyms": null
            },
            "indication": {
                "id": 2531,
                "name": "hematologic cancer",
                "source": "DOID"
            },
            "responseType": "conflicting",
            "references": [
                {
                    "id": 6082,
                    "pubMedId": 21330321,
                    "title": "The kinase inhibitor TKI258 is active against the novel CUX1-FGFR1 fusion detected in a patient with T-lymphoblastic leukemia/lymphoma and t(7;8)(q22;p11).",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21330321"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "molecularProfiles": [
        {
            "id": 24416,
            "profileName": "CUX1 - FGFR1",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        
    ]
}